{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:31:12Z","timestamp":1775061072672,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.rmed.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T07:09:20Z","timestamp":1476515360000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses"],"prefix":"10.1016","volume":"120","author":[{"given":"Donald P.","family":"Tashkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina B.","family":"Zubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Metzdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dacheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Clerisme-Beaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2016.10.002_bib1","series-title":"Global Strategy for the Diagnosis, Management and Prevention of COPD. Updated D2016","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2016"},{"issue":"7","key":"10.1016\/j.rmed.2016.10.002_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1513\/pats.200603-093SS","article-title":"Chronic obstructive pulmonary disease: the disease and its burden to society","volume":"3","author":"Halpin","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2016.10.002_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2466-14-102","article-title":"Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD","volume":"14","author":"Koskela","year":"2014","journal-title":"BMC Pulm. Med."},{"issue":"133","key":"10.1016\/j.rmed.2016.10.002_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1183\/09059180.00007813","article-title":"Depression and anxiety in patients with COPD","volume":"23","author":"Yohannes","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2016.10.002_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7525-8-39","article-title":"Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ","volume":"8","author":"Menn","year":"2010","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"10.1016\/j.rmed.2016.10.002_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2010.09.004","article-title":"Health-related quality of life in patients by COPD severity within primary care in Europe","volume":"105","author":"Jones","year":"2011","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2016.10.002_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl B","key":"10.1016\/j.rmed.2016.10.002_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St George's respiratory questionnaire","volume":"85","author":"Jones","year":"1991","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2016.10.002_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A\u00a0self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2016.10.002_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2016.10.002_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's respiratory questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.rmed.2016.10.002_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials","volume":"189","author":"Jones","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.10.002_bib13","article-title":"Tiotropium versus placebo for chronic obstructive pulmonary disease","volume":"7","author":"Karner","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.10.002_bib14","article-title":"Aclidinium bromide for stable chronic obstructive pulmonary disease","volume":"9","author":"Ni","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.rmed.2016.10.002_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40261-013-0138-1","article-title":"ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients","volume":"33","author":"Rennard","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.rmed.2016.10.002_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/COPD.S48967","article-title":"Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis","volume":"8","author":"Karabis","year":"2013","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"10.1016\/j.rmed.2016.10.002_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1465-9921-15-78","article-title":"Safety and tolerability of once-daily umeclidinium\/vilanterol 125\/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study","volume":"15","author":"Donohue","year":"2014","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2016.10.002_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09031936.00033213","article-title":"Umeclidinium in patients with COPD: a randomised, placebo-controlled study","volume":"43","author":"Trivedi","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2016.10.002_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40265-013-0058-7","article-title":"Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease","volume":"73","author":"Carter","year":"2013","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.rmed.2016.10.002_bib20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1183\/09031936.00040712","article-title":"Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study","volume":"40","author":"Kerwin","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2016.10.002_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1465-9921-12-156","article-title":"Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial","volume":"12","author":"D'Urzo","year":"2011","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.rmed.2016.10.002_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A\u00a0long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2016.10.002_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2016.10.002_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1378\/chest.127.3.809","article-title":"Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD","volume":"127","author":"Casaburi","year":"2005","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.rmed.2016.10.002_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A\u00a04-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2016.10.002_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/COPD.S3935","article-title":"Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance","volume":"3","author":"Ambrosino","year":"2008","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"2","key":"10.1016\/j.rmed.2016.10.002_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/COPD.S2463","article-title":"Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD","volume":"3","author":"Tonnel","year":"2008","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"8","key":"10.1016\/j.rmed.2016.10.002_bib28","first-page":"465","article-title":"A\u00a0randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease","volume":"14","author":"Chan","year":"2007","journal-title":"Can. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2016.10.002_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1378\/chest.12-2613","article-title":"Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trial","volume":"144","author":"Cooper","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.10.002_bib30","first-page":"197","article-title":"Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies","volume":"5","author":"Bateman","year":"2010","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"10","key":"10.1016\/j.rmed.2016.10.002_bib31","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.rmed.2010.06.004","article-title":"A\u00a0one-year trial of tiotropium Respimat\u00ae plus usual therapy in COPD patients","volume":"104","author":"Bateman","year":"2010","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2016.10.002_bib32","first-page":"559","article-title":"A\u00a0dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients","volume":"2","author":"Caillaud","year":"2007","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"2","key":"10.1016\/j.rmed.2016.10.002_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.rmed.2009.11.011","article-title":"Tiotropium 5\u03bcg via Respimat and 18\u03bcg via HandiHaler; efficacy and safety in Japanese COPD patients","volume":"104","author":"Ichinose","year":"2010","journal-title":"Respir. Med."},{"issue":"16","key":"10.1016\/j.rmed.2016.10.002_bib34","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium Respimat inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2016.10.002_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1378\/chest.93.1.123","article-title":"Fifteen-year interval spirometric evaluation of the Oregon predictive equations","volume":"93","author":"Morris","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.10.002_bib36","first-page":"7","article-title":"Standardised lung function testing of the European Community for coal and Steel","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull. Eur. Physiopath Resp."},{"key":"10.1016\/j.rmed.2016.10.002_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1465-9921-12-40","article-title":"Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review","volume":"12","author":"Westwood","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2016.10.002_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2466-14-178","article-title":"Efficacy and safety of aclidinium bromide\/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study","volume":"14","author":"Singh","year":"2014","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmed.2016.10.002_bib39","doi-asserted-by":"crossref","first-page":"e95305","DOI":"10.1371\/journal.pone.0095305","article-title":"Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010","volume":"9","author":"Ford","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2016.10.002_bib40","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1038\/npjpcrm.2014.15","article-title":"Trends in management and outcomes of COPD patients in primary care, 2000\u22122009: a retrospective cohort study","volume":"24","author":"James","year":"2014","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"10.1016\/j.rmed.2016.10.002_bib41","article-title":"Trends in mortality from chronic obstructive pulmonary disease among adults in the United States","author":"Ford","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2016.10.002_bib42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S2213-2600(13)70232-7","article-title":"Mortality trends in chronic obstructive pulmonary disease in Europe, 1994\u22122010: a joinpoint regression analysis","volume":"2","author":"L\u00f3pez-Campos","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2016.10.002_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.amjmed.2013.01.035","article-title":"Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease","volume":"126","author":"Baillargeon","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2016.10.002_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/COPD.S71913","article-title":"Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease","volume":"10","author":"Miravitlles","year":"2015","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:35:50Z","timestamp":1760614550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116302554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":44,"alternative-id":["S0954611116302554"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.10.002","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}